THERAPEUTIC MOLECULES

VARIABLES

PERIOD

P-VALUE

Intraocular pressure (mmHg)

At diagnosis

After one year of treatment

Beta-blockers

RIGHT EYE

20.9 ± 5.08

17.9 ± 5.28

<0.001

LEFT EYE

21.6 ± 5.34

18.0 ± 4.89

<0.001

Prostaglandin agonists

RIGHT EYE

23.0 ± 4.88

18.0 ± 2.96

0.007

LEFT EYE

23.9 ± 7.20

17.8 ± 3.66

0.019

Carbonic anhydrase inhibitors

RIGHT EYE

32.0 ± 2.40

19.2 ± 0.35

0.590

LEFT EYE

24.5 ± 6.36

26.5 ± 2.12

0.736

Beta-blockers + Carbonic anhydrase inhibitors

RIGHT EYE

28.3 ± 10.9

18.9 ± 6.57

<0.001

LEFT EYE

33.9 ± 11.5

20.8 ± 8.70

<0.001

Beta-blockers + Prostaglandin agonists

RIGHT EYE

23.8 ± 9.10

17.2 ± 3.79

0.002

LEFT EYE

23.6 ± 7.01

17.9 ± 7.08

0.005

Carbonic anhydrase inhibitors + Prostaglandin agonists

RIGHT EYE

35.5 ± 9.19

16.0 ± 1.41

0.198

LEFT EYE

23.0 ± 7.07

14.2 ± 1.63

0.316

Beta-blockers + Carbonic anhydrase inhibitors + Prostaglandin agonists

RIGHT EYE

37.1 ± 12.6

22.8 ± 11.7

0.101

LEFT EYE

39.5 ± 14.7

24.1 ± 12.3

0.112